Meno male ! la Glaxo e Google stanno investendo qualcosa come 715 milioni di dollari per lo start up di una società biotecnologica, che punta a produrre dei dispositivi che impiantati nel ns corpo permettono di intervenire su (alcuni) segnali del sistema nervoso patologici. Dispositivi bio-elettronici detti anche electro-ceutical (invece di pharma-ceutical) ... Glaxo and Verily Join Forces to Treat Disease By Hacking Your Nervous System Small implantable devices would treat people by blocking or altering signals sent from the brain. by Jamie Condliffe August 1, 2016 MIT Tech Review https://www.technologyreview.com/s/602049/glaxo-and-verily-join-forces-to-treat-disease-by-hacking-your-nervous-system/ GlaxoSmithKline and Google’s life sciences spin-off, Verily, are jointly funding a new venture that will investigate how tiny bioelectronic devices can be used to modify nerve signals and treat chronic diseases. The pair are investing $715 mil
